| Application no. and date | 15802815.9 (espacenet) (Federated) (European Patent Register), 20150604 | | Patent/reg. no. and date | DK/EP 3151853, 20200506 | | Publication date | 20170412 | | Priority no. and date | SE 1450678, 20140604, SE 1451315, 20141104 | | EP pub. no. and date |
EP 3151853 20170412 | | Effective date | | | Applicant/owner | Diamyd Medical AB, Box 7349
103 90 Stockholm , SE | | Applicant ref. no. | P41402779DK00E | | Inventor | ESSEN-MÖLLER, Anders, c/o Diamyd Medical AB
Kungsgatan 29
S-111 56 Stockholm, SE,
LUDVIGSSON, Johnny, c/o Linköpings Universitet
S-581 83 Linköping, SE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/592 (2006.01) , A61K 31/593 (2006.01) , A61K 38/51 (2006.01) , A61K 39/00 (2006.01) , A61P 3/10 (2006.01) , A61P 37/06 (2006.01) | | Title | Glutaminsyre-decarboxylase (GAD) til anvendelse ved behandling af en autoimmun sygdom | | Int. application no. | SE2015050651 | | Int. publication no. | WO2015187087 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
